Lung cancer risk is linked with accelerated biological aging and clonal hematopoiesis of indeterminate potential in human cohorts, including GrimAge and DunedinPACE associations adjusted for age and smoking. Longer telomeres are also linked with higher risk. Observational studies associate smoking and particulate air pollution with higher risk, while a human trial reports lower lung cancer incidence with Centrum Silver.
499 findings in 332 papers from 1985 to 2026, 118 of them since April 2026
“with significantly higher incidence in the LDCT + group (21.8 % vs 3.0 %, p < 0.0001)”
Chest radiography showed no clear effect on lung cancer in individuals who smoke (OR = 0.50, 95% CI 0.09-2.74).
“Chest radiography demonstrated a lower but statistically nonsignificant rate of lung cancer detection compared with controls (odds ratio OR = 0.50; 95% confidence intervals: 0.09-2.74).”
Lung cancer decreases MAX in tumor tissue vs tumor-free tissue (p < 0.01).
“Correspondingly, TT showed down-regulation of gene expression (p < 0.01) with strong inverse associations to hypermethylation; CAV1 was the exception, demonstrating up-regulation with hypomethylation in NSCLC TT.”
Lung cancer increases DNA methylation in tumor tissue vs tumor-free tissue (68.45%, 56.94%, and 75.97% vs 20.42%, 15.28%, and 29.57% (p < 0.05 to p < 0.001)).
“In TT, methylation frequencies for MAX, MTURN and HLA-B were significantly elevated 68.45%, 56.94%, and 75.97%—compared with TF (20.42%, 15.28%, and 29.57%; p < 0.05 to p < 0.001).”
Lung cancer is linked with higher terpenoids in lung cancer patients vs healthy controls.
“LC patients exhibited markedly increased levels of terpenoids and aldehydes, consistent with heightened oxidative stress, including lipid peroxidation, and perturbed metabolic pathways”
Humansin lung cancer patients vs healthy controlsurine
Lung cancer is linked with lower rectus femoris cross-sectional area in humans (compared to benign controls).
“Lung cancer patients exhibited lower RFthick, RFcsa, and CSmean but higher RFmgv compared to benign controls, with significant differences in RFcsa, RFmgv, and CSmean among the groups (P < .05).”
Lung cancer is linked with higher non-cancer mortality in humans (beyond 5 years post-diagnosis) (SMR 2.24 (95% CI 2.22-2.26)).
“Non-cancer-related deaths rose significantly over time, increasing from 7.72% within 1 year to 53.97% beyond 5 years post-diagnosis (overall SMR = 2.24, 95% CI 2.22-2.26)”
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·
Gamma-glutamylglutamine is linked with lung cancer in humans (for particulate matter and ozone).
“Four metabolites, including γ-glutamylglutamine, phenylacetylglutamate, N-(2-furoyl)glycine, and 4-vinylguaiacol glucuronide, significantly mediate associations for particulate matter and ozone”
Smoking is associated with lung cancer in humans (lung transplant recipients) (HR 1.82).
“donor smoking history (HR 1.82), ILD/pulmonary fibrosis (HR 1.49), older recipient age (HR 1.37 per 10 years), and cumulative recipient smoking exposure (HR 1.13 per 10 pack-years) were associated with LC development.”
Chinese medical journal pulmonary and critical care medicine·
Smoking is linked with a higher risk of lung cancer in humans (current cigarette smokers) (8.85% versus 5.74%).
“The 5-year cumulative lung cancer incidence in people who currently smoked both types of tobacco products was 8.85%, versus 5.74% for cigarette only current smokers.”
Smoking is associated with lung cancer in humans (multivariable Spatial Error Model across U.S. counties) (Estimate = 2.04, p < 0.001).
“spatial regression revealed this ecological pattern was primarily driven by geographic disparities in smoking prevalence (Estimate = 2.04, p < 0.001)”
Humansmultivariable Spatial Error Model across U.S. countiesn = 2,701
Fine particulate matter is linked with a higher risk of lung cancer in humans (multi-pollutant model, per 1-μg/m3 increase) (HR 1.008 (95% CI: 1.005, 1.011) per 1-μg/m3 increase).
“Specifically, the HR was 1.008 (95% confidence interval [CI]: 1.005, 1.011) per 1-μg/m3 increase in PM2.5”
Journal of toxicology and environmental health. Part B, Critical reviews·
Fine particulate matter raises the risk of lung cancer in silico (long-term exposure (28.4 μg/m3 vs baseline) in Errachidia) (RR = 1.30, 95% CI, 1.17-1.42).
“28.4 μg/m3 in southern Errachidia (RR = 1.30, 95% CI, 1.17-1.42; AP = 23.29%).”
In silicolong-term exposure (28.4 μg/m3 vs baseline) in Errachidia
Telomere length is linked with a higher risk of lung cancer in humans (OR 1.6009, 95% CI 1.3056-1.9629).
“The findings indicated significant positive associations between LTL and the risk of developing lung cancer [odds ratio (OR) = 1.6009, 95% confidence interval (CI) 1.3056-1.9629, P = 6.08 × 10−6]”
Telomere length is linked with a higher risk of lung cancer in humans (per 1-SD increase due to germline genetic variants) (OR 2.19, 95% CI 1.60-3.08).
“followed by lung cancer [OR, 2.19 (95% CI, 1.60-3.08) and 1.45 (1.12-1.87)]”
Humansper 1-SD increase due to germline genetic variants
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·
Lung cancer is associated with telomere length in humans (COPD smokers 3 years prior to lung cancer diagnosis) (p < 0.001).
“showed greater telomere length (p < 0.001) and increased serum 8-OHdG levels (p = 0.004) three years prior to LC diagnosis compared to the controls”
HumansCOPD smokers 3 years prior to lung cancer diagnosis
Telomere length is linked with a higher risk of lung cancer in humans (overall and particularly in never smokers) (p-trendcontinuous=2.6×10−5).
“we found dose-response relationships between longer phenotypic LTL (p-trendcontinuous=2.6×10−5), longer gTL predicted using a polygenic score with 130 genetic instruments (p-trendcontinuous=4.2×10−10), and overall lung cancer risk”
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·
Telomere length is linked with a higher risk of lung cancer in humans (multivariate Cox model) (HR 1.09 [95% CI 1.03-1.16]).
“An increase in LTL per interquartile range (IQR) was associated with a 9% increase in the risk for lung cancer (hazard ratio [HR] 1.09 [95% confidence interval (CI) 1.03-1.16]).”
Smoking cessation is linked with a lower risk of lung cancer in humans among FOXO3-G carriers; per additional year of smoking cessation (HR 0.87; 95% CI 0.81-0.94).
“each additional year of smoking cessation was associated with a reduced risk of LC (HR, 0.87; 95% CI, 0.81-0.94)”
Humansamong FOXO3-G carriers; per additional year of smoking cessationmales
Smoking cessation is associated with lung cancer in humans (Patients with COPD; smoking cessation compared with continued smoking) (aHR 0.85, 95% CI 0.72–0.99).
“quitters had significantly lower risks of lung cancer (adjusted HR [aHR], 0.85; 95% CI, 0.72–0.99)”
HumansPatients with COPD; smoking cessation compared with continued smokingn = 23,262
Smoking cessation is linked with a lower risk of lung cancer in humans (carrying C > A/G > T mutation) (39.5% decrease).
“Men ≥ 65 carrying C > A/G > T mutation had the highest lung cancer incidence decrease of 39.5% after five years quitting in stratified elderly groups”
Humanscarrying C > A/G > T mutationfive yearsmales
GrimAge is linked with a higher risk of lung cancer in humans.
“All three algorithms showed strong positive associations with lung cancer risk in a dose response manner, with adjusted HRs per SD increase in AgeAccelPheno, AgeAccelGrim, and MRscore-8CpGs, of 1·37 (1·03-1·82), 1·74 (1·11-2·73)”
Chronic obstructive pulmonary disease raises the risk of lung cancer in lung transplant candidates, mainly previous smokers.
“Lung transplant candidates at higher risk for developing lung cancer [mainly previous smokers with chronic obstructive lung disease (COPD) and idiopathic pulmonary fibrosis (IPF) or older patients]”
Low-dose computed tomography screening is associated with lung cancer in humans (post-2014 guideline era in adults aged 55-79 years) (annual AAMR decreased by 3.03% in CDC WONDER and 2.58% in GBD).
“Annual AAMR decreased by 3.03% in CDC WONDER and 2.58% in GBD; AAIR declined by 1.85% and 2.37%, respectively.”
Humanspost-2014 guideline era in adults aged 55-79 years
Sybil predicts lung cancer in humans (Tertiary safety-net hospital lung cancer screening cohort) (Overall AUC 0.819–0.912; 2-year AUC 0.746 in Lung-RADS 1 and 2 cases).
“Sybil's overall area under the curve (AUC) ranged from 0.819 to 0.912; while its 2-year AUC for Lung-RADS 1 and 2 cases was 0.746.”
HumansTertiary safety-net hospital lung cancer screening cohortlungn = 3,120
Neutrophil-to-lymphocyte ratio is linked with a higher risk of lung cancer in current smokers with high inflammatory marker levels (AHR=3.78; 95% CI: 2.65-5.39).
“NLR: AHR=3.78; 95% CI: 2.65-5.39”
Humansin current smokers with high inflammatory marker levelsmales
Neutrophil-to-lymphocyte ratio is associated with lung cancer in humans.
“Sex-stratified analyses revealed stronger associations between Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune Inflammatory Index (SII) and lung cancer in men”
Tuberculosis is linked with a higher risk of lung cancer in humans.
“lung cancer was independently associated with low education, wealth, solid-fuel use, occupational exposure, insufficient physical activity, meat-based and processed food dietary patterns, secondhand smoke (SHS), prior tuberculosis, and family history of cancer.”
Human observational studies associate epigenetic age acceleration, clonal hematopoiesis and longer telomeres with higher lung cancer risk, with some epigenetic associations persisting after adjustment for smoking. A human trial reports lower lung cancer risk with Centrum Silver multivitamins.
Human studies associate higher lung cancer risk with clonal hematopoiesis, faster blood epigenetic aging and metabolic syndrome; preprints also link imaging-derived age acceleration to risk. Higher dietary quality and healthy lifestyles associate with lower risk, whereas air pollution associates with higher risk. Total bilirubin-to-albumin ratio associates with lower risk in males but higher risk in females.
Summary rewritten as its findings changed.
As it read before
Human studies associate smoking, metabolic syndrome and higher polygenic risk scores with greater lung cancer risk, and Mediterranean diet and healthy lifestyle with lower risk. Screening is associated with increased early-stage but decreased late-stage incidence in humans. Human trials assess low-dose computed tomography and the ITALUNG biomarker panel for prediction; reviews link air pollution to increased risk.
Summary rewritten as its findings changed.
As it read before
Human cohort studies link particulate ions, microplastics, ASXL1 mutations, smoking, and medical debt to increased lung cancer risk, while sleep and dietary polyunsaturated fatty acids are associated with reduced risk. Reviews also link air pollution, tuberculosis, and Y-chromosome loss.
Twofold higher levels of four blood fats were linked to 50% to over 400% higher relative risks of chronic respiratory and lung cancer death.Twofold higher levels of four blood fats were linked to 50% to over 400% higher relative risks of chronic respiratory and lung cancer death.
Genome sequencing in 55 people with lung cancer found comparable levels of candidate mobile DNA insertions in tumors and nearby normal-looking lung tissue.Genome sequencing in 55 people with lung cancer found comparable levels of candidate mobile DNA insertions in tumors and nearby normal-looking lung tissue.
High-fitness men with colorectal, lung or prostate cancer had a 33–41% lower relative risk of death from any cause than low-fitness men.High-fitness men with colorectal, lung or prostate cancer had a 33–41% lower relative risk of death from any cause than low-fitness men.
Men with low predicted muscle mass had a hazard ratio of 1.04 for overall cancer versus other men—a small difference in relative risk.Men with low predicted muscle mass had a hazard ratio of 1.04 for overall cancer versus other men—a small difference in relative risk.